|
|
|
Out-of-Pocket Healthcare 2012
4/3/2012 | published by: Kalorama Information
Despite numerous attempts to reign in costs of healthcare, consumers are increasingly paying for healthcare products and services from their own monies. The costs of health care products and services continue
|
more...
|
$995.00
|
|
World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)
3/1/2012 | published by: Kalorama Information
This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the eighth time that Kalorama has detailed the various categories of prescription dermatological drugs, describing the global market and identifying major market factors
|
more...
|
$3,995.00
|
|
Targeted Health and Wellness Foods and Beverages: The U.S. Market and Global Trends
3/1/2012 | published by: Packaged Facts
The market for targeted health and wellness foods and beverages is a dynamic and promising one, driven largely by the growing recognition—among scientists, government, practitioners, and consumers alike—of the instrumental role diet plays in a
|
more...
|
$3,500.00
|
|
Chinese Markets for Hepatitis Drugs
4/1/2012 | published by: Asia Market Information & Development Company
China's demand for hepatitis drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic
|
more...
|
$4,000.00
|
|
The US Pharmaceutical Market Outlook to 2016 - Evolving Opportunities in the Biologics Segment
3/1/2012 | published by: AM Mindpower Solutions
EXECUTIVE SUMMARY The report titled “The US Pharmaceutical Market Outlook to 2015 – Evolving Opportunities in the Biologics Segment” provides a comprehensive analysis on the Pharmaceutical market in the US covering various aspects such as market
|
more...
|
$850.00
|
|
FDA Approves Erivedge (Vismodegib) for Metastatic or Locally Advanced Basal Cell Carcinoma
2/29/2012 | published by: GlobalData
FDA Approves Erivedge (Vismodegib) for Metastatic or Locally Advanced Basal Cell Carcinoma Summary GlobalData, the industry analysis specialist, has released its new report, “FDA Approves Erivedge (Vismodegib) for Metastatic or Locally Advanced Basal Cell Carcinoma”. The report
|
more...
|
$500.00
|
|
Uk Cardiovascular Monitoring Systems Market - Present and Future Trends Until 2018
4/4/2012 | published by: ABMRG
This research report provides key market trends, market forecasts and competitive scenario of the cardiovascular monitoring systems in the UK through 2018. The product categories covered in this report include: ECG Monitoring Equipment (Electrocardiogram)
|
more...
|
$2,000.00
|
|
Canada Cardiovascular Monitoring Systems Market - Present and Future Trends Until 2018
4/2/2012 | published by: ABMRG
This research report provides key market trends, market forecasts and competitive scenario of the cardiovascular monitoring systems in Canada through 2018. The product categories covered in this report include: ECG Monitoring Equipment (Electrocardiogram)
|
more...
|
$2,000.00
|
|
US Cardiovascular Monitoring Systems Market - Present and Future Trends Until 2018
4/2/2012 | published by: ABMRG
This research report provides key market trends, market forecasts and competitive scenario of the cardiovascular monitoring systems in the US through 2018. The product categories covered in this report include: ECG Monitoring Equipment (Electrocardiogram)
|
more...
|
$2,000.00
|
|
Germany Cardiovascular Monitoring Systems Market - Present and Future Trends Until 2018
3/27/2012 | published by: ABMRG
This research report provides key market trends, market forecasts and competitive scenario of the cardiovascular monitoring systems in Germany through 2018. The product categories covered in this report include: ECG Monitoring Equipment (Electrocardiogram)
|
more...
|
$2,000.00
|
Related Markets
Cardiovascular Reports
- Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution
- Cardiovascular Partnering Terms and Agreements
- International Stroke Conference 2012 - Post-Conference Review and Analysis
- 6th Asian Pacific Congress of Heart Failure (APCHF) - Post-Conference Review and Analysis
- Arrhythmias Global Clinical Trials Review, H1, 2012
